KCNH2 and familial long QT syndrome: In addition, 100 nM AST was also added to the hiPSC‐CMs carrying LQTS mutations, thus simulating in vitro what happens to LQT mutation carriers treated with hERG blocking drugs (Kannankeril et al, 2010; Schwartz, 2015).